Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

The opioid antagonist, β-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice.

Davis RL, Stevens CW, Thomas Curtis J.

Physiol Behav. 2017 May 1;173:52-60. doi: 10.1016/j.physbeh.2017.01.037. Epub 2017 Jan 24.

PMID:
28130086
2.

The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice.

Davis RL, Das S, Thomas Curtis J, Stevens CW.

Eur J Pharmacol. 2015 Sep 5;762:193-201. doi: 10.1016/j.ejphar.2015.05.040. Epub 2015 May 22.

3.

Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.

Davis RL, Das S, Buck DJ, Stevens CW.

Neurochem Int. 2013 Mar;62(4):478-85. doi: 10.1016/j.neuint.2013.01.013. Epub 2013 Jan 31.

4.

α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells.

Tousi NS, Buck DJ, Curtis JT, Davis RL.

Neurosci Lett. 2012 Jan 24;507(2):133-6. doi: 10.1016/j.neulet.2011.12.001. Epub 2011 Dec 13.

5.

Chronic inorganic mercury exposure induces sex-specific changes in central TNFα expression: importance in autism?

Thomas Curtis J, Chen Y, Buck DJ, Davis RL.

Neurosci Lett. 2011 Oct 17;504(1):40-4. doi: 10.1016/j.neulet.2011.08.053. Epub 2011 Aug 31. Erratum in: Neurosci Lett. 2011 Nov 21;505(3):294.

6.

Neuromelanin inhibits CXCL10 expression in human astroglial cells.

Tousi NS, Buck DJ, Zecca L, Davis RL.

Neurosci Lett. 2010 Dec 3;486(1):47-50. doi: 10.1016/j.neulet.2010.09.042. Epub 2010 Sep 17.

7.

Going...going...going...gone green. Making your dental practice environmentally friendly.

DeMello MC, Clancy RM, McMillan J, McMillan R, Henry K, Bommhardt C; Virginia Dental Association; Virginia Department of Environmental Quality, Molinari JA; Council on Dental Practice; Standing Committee on the New Dentist.

J Mass Dent Soc. 2010 Summer;59(2):29-32. No abstract available.

PMID:
20806702
8.

Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk.

Mohan S, Davis RL, DeSilva U, Stevens CW.

J Neuroimmunol. 2010 Oct 8;227(1-2):26-34. doi: 10.1016/j.jneuroim.2010.06.007. Epub 2010 Jul 7.

9.

Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes.

Williams R, Dhillon NK, Hegde ST, Yao H, Peng F, Callen S, Chebloune Y, Davis RL, Buch SJ.

Glia. 2009 May;57(7):734-43. doi: 10.1002/glia.20801.

10.

Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells.

Davis RL, Buck DJ, Saffarian N, Mohan S, DeSilva U, Fernando SC, Stevens CW.

J Neuroimmune Pharmacol. 2008 Sep;3(3):150-3. doi: 10.1007/s11481-008-9102-x. Epub 2008 Feb 16.

11.
12.

The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Davis RL, Buck DJ, Saffarian N, Stevens CW.

J Neuroimmunol. 2007 May;186(1-2):141-9. Epub 2007 May 1.

13.

Interactions of alcohol and nitric-oxide synthase in the brain.

Davis RL, Syapin PJ.

Brain Res Brain Res Rev. 2005 Nov;49(3):494-504. Epub 2005 Mar 5. Review.

PMID:
16269316
14.

Soil characteristics and phosphorus level effect on phosphorus loss in runoff.

Davis RL, Zhang H, Schroder JL, Wang JJ, Payton ME, Zazulak A.

J Environ Qual. 2005 Aug 9;34(5):1640-50. Print 2005 Sep-Oct.

PMID:
16091617
15.

Effects of mechanistically distinct NF-kappaB inhibitors on glial inducible nitric-oxide synthase expression.

Davis RL, Sanchez AC, Lindley DJ, Williams SC, Syapin PJ.

Nitric Oxide. 2005 Jun;12(4):200-9.

PMID:
15890551
16.

Ethanol increases nuclear factor-kappa B activity in human astroglial cells.

Davis RL, Syapin PJ.

Neurosci Lett. 2004 Nov 23;371(2-3):128-32.

PMID:
15519742
18.
19.
20.

The effect of taurine supplementation on patients with type 2 diabetes mellitus.

Chauncey KB, Tenner TE Jr, Lombardini JB, Jones BG, Brooks ML, Warner RD, Davis RL, Ragain RM.

Adv Exp Med Biol. 2003;526:91-6. No abstract available.

PMID:
12908588

Supplemental Content

Loading ...
Support Center